Tadacip 20 mg: Price, Availability & U.S. Status

Tadacip 20 is a branded tadalafil 20 mg film-coated tablet associated with Cipla. Current Australian regulator records list TADACIP 20 tadalafil 20 mg film-coated tablets on the Australian Register of Therapeutic Goods with an active registration and Cipla Australia Pty Ltd as sponsor. This is a product-specific registration in Australia; it should not be confused with the separate FDA approvals for tadalafil products in the United States.

Tadacip 20 product identity

The Australian TGA record identifies the product as TADACIP 20 tadalafil 20 mg film-coated tablets, ARTG 274228. Australian medicine information also lists Tadacip strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, with the 20 mg version described as a yellow, capsule-shaped, biconvex film-coated tablet marked “T 20.”

The current Australian sponsor is Cipla Australia Pty Ltd. A Ugandan national drug register historically identified Tadacip 20 as a Cipla Ltd product and listed a Cipla manufacturing site in Goa, India. Because manufacturing sites and supply arrangements can change by market and over time, the current package and local regulator record should be checked when manufacturer-site precision matters.

Tadacip versus tadalafil

Tadalafil is the active ingredient; Tadacip is a specific Cipla-associated brand. In the United States, tadalafil is an FDA-approved prescription ingredient available in approved products and generic applications, including 20 mg tablets. The existence of those U.S. tadalafil approvals does not automatically establish FDA approval for the Tadacip brand.

For commercial product research, compare the exact brand and regulator record rather than treating “Tadacip,” “Cialis” and “generic tadalafil” as interchangeable product names.

Prescription and U.S. regulatory context

In Australia, Tadacip is Schedule 4 and the consumer medicine information states that it is available only with a doctor's prescription. In the United States, FDA-approved tadalafil tablets are also prescription drugs.

No U.S. approval for the exact Tadacip brand is established by the authoritative sources used for this page. The strongest current product-specific regulatory record reviewed is the Australian TGA registration. A U.S. patient should therefore verify the exact product in Drugs@FDA or the Orange Book rather than assuming that a foreign-market Tadacip pack is an FDA-approved U.S. tadalafil product.

Tadacip 20 price and availability context

Price comparisons depend heavily on market. An Australian registered product, an Indian pack and an FDA-approved U.S. tadalafil generic can have different wholesalers, package sizes, reimbursement rules and retail channels. A web price for Tadacip should not be compared directly with a U.S. insurance copay or cash price for an FDA-approved tadalafil prescription without first confirming that the products and markets are actually comparable.

Current availability should be checked with a licensed pharmacy in the relevant jurisdiction. Davidson Pharmacy's inventory, sale price, online dispensing or shipping availability for Tadacip is not asserted here.

What to verify before obtaining a tadalafil product

• Confirm whether the intended product is specifically Tadacip 20 or another tadalafil product.
• Verify the 20 mg strength, film-coated tablet form and current package labeling.
• Check the sponsor/manufacturer information for the country in which the product is being supplied.
• Confirm prescription requirements and local product authorization.
• Review major interactions. U.S. tadalafil labeling contraindicates use with organic nitrates and warns about additive blood-pressure effects with some other vasodilators.

Related Davidson men's-health medication guides

For another tadalafil-brand research page, see Vidalista 20 mg. To compare tadalafil with sildenafil and dapoxetine products, return to the Men's Health Prescription Medication Guide.

Research sources

Product-specific statements are based on Australian TGA and medicine-information records, with a historical national drug register used only to document a Cipla manufacturing record. U.S. ingredient and prescription context is based on FDA/DailyMed sources.

• Therapeutic Goods Administration (Australia) — TADACIP 20 tadalafil 20 mg film-coated tablet, ARTG 274228, active registration, sponsor Cipla Australia Pty Ltd
• Australian Commission on Safety and Quality in Health Care — Tadacip product information and prescription status
• DailyMed — current U.S. tadalafil labeling, including 20 mg and Rx status
• Uganda National Drug Authority — historical national register entry for TADACIP 20, Cipla Ltd and Goa manufacturing site
• DailyMed — tadalafil contraindications and nitrate interaction